EDA - Notice to applicant : Central Administration of Drug Control

Sorry, this website does not support this browser

Notice to applicant : Central Administration of Drug Control

Date	Des.	Issue No.
08/2022	Submission of New Template for Certificate of Analysis of Working Standard	01
11/2022	Inquiries and Complaints Procedure in the Central Administration of Drug Control	01
04/2023	Prioritization of Vital and Strategic Products, or Products Produced for Export, for File Review and Analysis	01
06/2024	The mechanism for obtaining subsidized-price reference standards from the American Pharmacopeia	02
11/2024	Submission of Application Form and CMC Differences Form for Application to Reliance Pathway	01
08/2025	Advisory Note on Mitigation of Risks of Nitrosamine Impurities in Pharmaceutical Products	01
04/2026	EDA PT Catalogue	01
07/2026	New Procedure for File Review for Products Submitted to PAC for Analysis	02

FQS Notice to applicant

Date	Des	Issue No.
04/2023	FAQs for EDA Pharm Lab Accreditation Program	01
01/2025	Frequently Asked Questions (Technical assessment and sample analysis)	02
02/2025	The most frequently asked questions for the Egyptian Drug Authority Certification of Reference Materials Program	02

Copy Rights @ EDA 2021